Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

303 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii.
Vila J, Martí S, Sánchez-Céspedes J. Vila J, et al. J Antimicrob Chemother. 2007 Jun;59(6):1210-5. doi: 10.1093/jac/dkl509. Epub 2007 Feb 26. J Antimicrob Chemother. 2007. PMID: 17324960 Review.
The ability to acquire multidrug resistance can be due to either the acquisition of genetic elements carrying multiple resistant determinants or mutations affecting the expression of porins and/or efflux pump(s), which can affect unrelated antimicrobial agents. ...This rev …
The ability to acquire multidrug resistance can be due to either the acquisition of genetic elements carrying multiple resistant determinant …
[Prevalence of the tetA and tetB genes as mechanisms of resistance to tetracycline and minocycline in Acinetobacter baumannii clinical isolates].
Martí S, Fernández-Cuenca F, Pascual A, Ribera A, Rodríguez-Baño J, Bou G, Miguel Cisneros J, Pachón J, Martínez-Martínez L, Vila J; Grupo de Estudio de Infección Hospitalaria (GEIH). Martí S, et al. Enferm Infecc Microbiol Clin. 2006 Feb;24(2):77-80. doi: 10.1157/13085012. Enferm Infecc Microbiol Clin. 2006. PMID: 16545313 Spanish.
Nosocomial bacteremia due to an as yet unclassified acinetobacter genomic species 17-like strain.
Rodriguez-Baño J, Martí S, Ribera A, Fernández-Cuenca F, Dijkshoorn L, Nemec A, Pujol M, Vila J. Rodriguez-Baño J, et al. J Clin Microbiol. 2006 Apr;44(4):1587-9. doi: 10.1128/JCM.44.4.1587-1589.2006. J Clin Microbiol. 2006. PMID: 16597902 Free PMC article.
Genotypic diversity of imipenem resistant isolates of Acinetobacter baumannii in Spain.
Oteo J, García-Estébanez C, Migueláñez S, Campos J, Martí S, Vila J, Domínguez MA, Docobo F, Larrosa N, Pascual A, Pintado V, Coll P; Red Española de Investigación en Patología Infecciosa. Oteo J, et al. J Infect. 2007 Sep;55(3):260-6. doi: 10.1016/j.jinf.2007.04.009. Epub 2007 Jun 14. J Infect. 2007. PMID: 17570530 Clinical Trial.
High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain.
Ruiz M, Marti S, Fernandez-Cuenca F, Pascual A, Vila J. Ruiz M, et al. Clin Microbiol Infect. 2007 Dec;13(12):1192-8. doi: 10.1111/j.1469-0691.2007.01825.x. Epub 2007 Sep 10. Clin Microbiol Infect. 2007. PMID: 17850347
Biofilm formation in Acinetobacter baumannii: associated features and clinical implications.
Rodríguez-Baño J, Martí S, Soto S, Fernández-Cuenca F, Cisneros JM, Pachón J, Pascual A, Martínez-Martínez L, McQueary C, Actis LA, Vila J; Spanish Group for the Study of Nosocomial Infections (GEIH). Rodríguez-Baño J, et al. Clin Microbiol Infect. 2008 Mar;14(3):276-8. doi: 10.1111/j.1469-0691.2007.01916.x. Epub 2008 Jan 10. Clin Microbiol Infect. 2008. PMID: 18190568 Clinical Trial.
Characterization of the carbapenem-hydrolyzing oxacillinase OXA-58 in an Acinetobacter phenon 6/ct13TU clinical isolate.
Marti S, Sánchez-Céspedes J, Blasco MD, Espinal P, Ruiz M, Alba V, Vila J. Marti S, et al. Diagn Microbiol Infect Dis. 2008 Aug;61(4):468-70. doi: 10.1016/j.diagmicrobio.2008.03.014. Epub 2008 May 15. Diagn Microbiol Infect Dis. 2008. PMID: 18485655
Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.
Marti S, Sánchez-Céspedes J, Blasco MD, Ruiz M, Espinal P, Alba V, Fernández-Cuenca F, Pascual A, Vila J. Marti S, et al. Antimicrob Agents Chemother. 2008 Aug;52(8):2955-8. doi: 10.1128/AAC.00072-08. Epub 2008 May 27. Antimicrob Agents Chemother. 2008. PMID: 18505859 Free PMC article.
303 results
Jump to page
Feedback